ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2399

Rheumatoid Arthritis Have Lower Glomerular Filtration Rate Compared to Healthy Population: Role of Inflammation

Suad Hannawi1 and Issa Al Salmi2, 1Rheumatology, Asst.Prof, Dubai, United Arab Emirates, 2Prof, Muscat, Oman

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Cardiovascular disease, inflammation and rheumatoid arthritis (RA), Kidney

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Rheumatoid Arthritis – Clinical Aspects Poster III: Comorbidities

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Rheumatoid Arthritis-(RA) is associated with subclinical kidney impairment which contributes to increase mortality and morbidity. The role of inflammation on kidney function in inflammatory arthritis is not well studied. The purpose of this stufy is to investigate associations between estimated-glomerular-filtration-rates(eGFR), traditional cardiovascular risk factors, and markers of inflammation in RA compared to healthy controls.

Methods:

Participants were recruited from a specialized rheumatology clinic at Ministry of Health and Prevention of UAE, from January 2013 to January 2016. Healthy subjects recruited from the community through brochure advertisement. The Modification-of-Diet-in-Renal- Disease-Study-MDRD-formula was used to calculate the eGFR. ttest and compare laboratory values and kidney function parameters between two groups. Linear regression analysis used to look for the correlation between the eGFR and each of the traditional cardiovascular risk factors and inflammatory markers.

Results:

98 RA-patients and 82-controls were recruited. None of the participants has history of diabetes, atherosclerosis or kidney impairment. The mean age for total participants was 49 ±13 years (Min16 –Max 82). The mean eGFR of inflammatory arthritis patients was 118 ± 30 ml/min (range 60 – 227) and 128 ±37 ml/min (range 62 – 286) for the controls. Patients and control had no significant difference in Systolic-SBP and diastolic-blood-pressure-DBP.

Inflammatory arthritis patients had lower GFR, albumin (P<0.001), and total protein (p=0.03) levels, and had higher ESR (P<0.001), CRP (P<0.001), and uric acid level (p=0.01),

Negative linear relationships were found as follow: Among RA patients and controls; there was a negative linear relationship between GFR and each of: age of participants; (p<0.001, CI: -1.24, -0.40 for patients and p=0.01, CI: -1.82, -0.26 for controls, & SBP; (p= 0.04, CI: -0.61, -.00 for patients and p=0.022, CI: -0.61, -0.05 for controls.

Among RA patients: GFR had a negative linear relationship with age of participants, age at RA onset (p=0.002, CI: -1.18, -0.29), dbp (p=-2.14, CI: -1.24, -0.05), ESR (p=0.04, CI: -0.24,-0.01), CRP (p=0.02, CI: -0.47, -0.04), uric acid (p<0.001, CI -0.18, -0.05), and total protein (p= 0.01, CI: -0.91, -0.16). There was a positive linear relationship between eGFR and albumin level (p=0.03, p= 0.14, 2.35),

Conclusion:

non-traditional CVD risk factors such as inflammatory markers are associated with sub-clinical kidney injury in patients with RA. Inflammation is involved in the early stages of impaired kidney function in RA patients. Hence, anti-inflammatory therapies may be effective in slowing down the deterioration of kidney function in the arthritis diseases.


Disclosure: S. Hannawi, None; I. Al Salmi, None.

To cite this abstract in AMA style:

Hannawi S, Al Salmi I. Rheumatoid Arthritis Have Lower Glomerular Filtration Rate Compared to Healthy Population: Role of Inflammation [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/rheumatoid-arthritis-have-lower-glomerular-filtration-rate-compared-to-healthy-population-role-of-inflammation/. Accessed September 22, 2023.
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatoid-arthritis-have-lower-glomerular-filtration-rate-compared-to-healthy-population-role-of-inflammation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under embargo once the ACR has notified ­­­presenters of their abstract’s acceptance, and cannot be presented at other meetings after this time. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until November 7 at 10:00 AM ET. Journalists with access to embargoed information also cannot release articles before this time.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Permissions and Reprints

For information about abstract permissions and reprints, see ACR Convergence permissions and reprint policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2023 American College of Rheumatology